Literature DB >> 10461093

Penetration of titanium dioxide microparticles in a sunscreen formulation into the horny layer and the follicular orifice.

J Lademann1, H Weigmann, C Rickmeyer, H Barthelmes, H Schaefer, G Mueller, W Sterry.   

Abstract

Coated titanium dioxide (TiO2) microparticles are commonly used as UV filter substances in commercial sunscreen products. The penetration of these microparticles into the horny layer and the orifice of the hair follicle was investigated. The distribution of the microparticles in the horny layer was analyzed using the method of tape stripping in combination with spectroscopic measurements. Deeper layers of the stratum corneum were devoid of TiO(2) even after repetitive application of sunscreen preparation when analyzing interfollicular areas. Only in the areas of the pilosebaceous orifices could microparticles be identified. The penetration of TiO(2) was investigated in histological skin sections. A biopsy was taken from a skin area from which the horny layer had been removed by tape stripping. In isolated areas, a penetration of coated TiO2 into the open part of the follicle was observed. The amount of TiO2 found in a given follicle was less than 1% of the applied total amount of sunscreens. A penetration of microparticles into viable skin tissue could not be detected.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10461093     DOI: 10.1159/000066249

Source DB:  PubMed          Journal:  Skin Pharmacol Appl Skin Physiol        ISSN: 1422-2868


  59 in total

1.  [Follicular penetration. An important pathway for topically applied substances].

Authors:  J Lademann; N Otberg; H Richter; U Jacobi; H Schaefer; U Blume-Peytavi; W Sterry
Journal:  Hautarzt       Date:  2003-03-06       Impact factor: 0.751

2.  A critical evaluation of material safety data sheets (MSDSs) for engineered nanomaterials.

Authors:  Adrienne Eastlake; Laura Hodson; Charles Geraci; Carlos Crawford
Journal:  Chem Health Saf       Date:  2012 Sep-Oct

Review 3.  [Penetration of microparticles into human skin].

Authors:  J Lademann; H Schaefer; N Otberg; A Teichmann; U Blume-Peytavi; W Sterry
Journal:  Hautarzt       Date:  2004-12       Impact factor: 0.751

4.  Migration of intradermally injected quantum dots to sentinel organs in mice.

Authors:  Neera V Gopee; Dean W Roberts; Peggy Webb; Christy R Cozart; Paul H Siitonen; Alan R Warbritton; William W Yu; Vicki L Colvin; Nigel J Walker; Paul C Howard
Journal:  Toxicol Sci       Date:  2007-04-02       Impact factor: 4.849

Review 5.  [How safe are nanoparticles?].

Authors:  J Lademann; M Meinke; W Sterry; A Patzelt
Journal:  Hautarzt       Date:  2009-04       Impact factor: 0.751

6.  [Allergy diagnostics in suspected implant intolerance: practical approach. A position paper of the German Contact Dermatitis Research Group (DKG)].

Authors:  J Geier; H Lessmann; D Becker; P Thomas
Journal:  Hautarzt       Date:  2008-07       Impact factor: 0.751

7.  Drug targeting to the hair follicles: a cyclodextrin-based drug delivery.

Authors:  Fífa Konrádsdóttir; Helga Ogmundsdóttir; Valgardur Sigurdsson; Thorsteinn Loftsson
Journal:  AAPS PharmSciTech       Date:  2009-03-12       Impact factor: 3.246

8.  Doxorubicin liposomes as an investigative model to study the skin permeation of nanocarriers.

Authors:  Cedar H A Boakye; Ketan Patel; Mandip Singh
Journal:  Int J Pharm       Date:  2015-04-21       Impact factor: 5.875

Review 9.  Titanium dioxide nanoparticles: a review of current toxicological data.

Authors:  Hongbo Shi; Ruth Magaye; Vincent Castranova; Jinshun Zhao
Journal:  Part Fibre Toxicol       Date:  2013-04-15       Impact factor: 9.400

10.  Interactions between SIRT1 and AP-1 reveal a mechanistic insight into the growth promoting properties of alumina (Al2O3) nanoparticles in mouse skin epithelial cells.

Authors:  Swatee Dey; Vasudevan Bakthavatchalu; Michael T Tseng; Peng Wu; Rebecca L Florence; Eric A Grulke; Robert A Yokel; Sanjit Kumar Dhar; Hsin-Sheng Yang; Yumin Chen; Daret K St Clair
Journal:  Carcinogenesis       Date:  2008-08-01       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.